Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-022469
Filing Date
2021-03-22
Accepted
2021-03-22 20:43:57
Documents
1
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 5827
  Complete submission text file 0001209191-21-022469.txt   7871
Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 (650) 688-0818
Vivo Capital Fund IX, L.P. (Reporting) CIK: 0001750117 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-40215 | Film No.: 21762803

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Capital IX, LLC (Reporting) CIK: 0001750698 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-40215 | Film No.: 21762804

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)